Chris Halyk
Net worth: 26 974 $ as of 2026-06-29
Net worth: 26 974 $ as of 2026-06-29
Chris Halyk is currently an Independent Director at MediPharm Labs Corp.
since 2020.
Former roles include Chairman at Innovative Medicines Canada from 2012 to 2013, Managing Director at Ortho Biotech, Inc., and President at Janssen, Inc. from 2006 to 2019.
Education includes undergraduate studies at Richard Ivey School of Business.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
MEDIPHARM LABS CORP. 0.12% | 2026-06-08 | 528,906 ( 0.12% ) | 26 974 $ | 2026-06-29 |
| Companies | Position | Start |
|---|---|---|
| MEDIPHARM LABS CORP. | Director/Board Member | 2020-08-03 |
| Companies | Position | End |
|---|---|---|
Janssen, Inc.
Janssen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | President | 2018-12-31 |
Innovative Medicines Canada
Innovative Medicines Canada Miscellaneous Commercial ServicesCommercial Services Engages in research and development of medicines and vaccines | Chairman | 2012-12-31 |
Ortho Biotech, Inc. | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Ortho Biotech, Inc. | |
Innovative Medicines Canada
Innovative Medicines Canada Miscellaneous Commercial ServicesCommercial Services Engages in research and development of medicines and vaccines | Commercial Services |
Janssen, Inc.
Janssen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Health Technology |
Richard Ivey School of Business
Richard Ivey School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MediPharm Labs Corp.
MediPharm Labs Corp. Agricultural Commodities/MillingProcess Industries Engages in the pharmaceutical grade production of cannabis oil products | Process Industries |
Select your edition
All financial news and data tailored to specific country editions